| NCT ID | NCT06624358 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Philadelphia |
| Condition | Chronic Kidney Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-09-30 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-09-30 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this is to test the efficacy of a 12-week physical activity intervention in 64 adolescents with CKD.
Eligibility Criteria
Inclusion criteria: For adolescent participants: 1. Males or females age 13 - 18 years 2. Diagnosis of CKD stage II - V not yet on dialysis or with a transplant 3. English proficiency 4. Parental/guardian permission (informed consent), and if applicable, child assent For caregiver participants: 1. Parent/legal guardian of an enrolled adolescent participant 2. English proficiency Exclusion Criteria: For adolescent participants: 1. Pregnant or lactating 2. Non-ambulatory 3. Have high physical activity at baseline (\>45 min/day of MVPA) 4. Provide \<2 days of physical activity data during the run-in period 5. Have a condition, such as heart or lung disease, that preclude safely engaging in physical activity 6. Have received a solid organ transplant 7. Have limited English proficiency 8. Are on dialysis 9. In the opinion of the investigator, are unable to comply with the requirements of the study protocol or are unsuitable for the study for any reason For caregivers participants: 1\. Limited English proficiency
Contact & Investigator
Amy Kogon, MD MPH
PRINCIPAL INVESTIGATOR
Children's Hospital of Philadelphia
Frequently Asked Questions
Who can join the NCT06624358 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 18 Years, studying Chronic Kidney Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06624358 currently recruiting?
Yes, NCT06624358 is actively recruiting participants. Contact the research team at loguidicej@chop.edu for enrollment information.
Where is the NCT06624358 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT06624358 clinical trial?
NCT06624358 is sponsored by Children's Hospital of Philadelphia. The principal investigator is Amy Kogon, MD MPH at Children's Hospital of Philadelphia. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.